Organon & Co. (OGN)
(Delayed Data from NYSE)
$18.55 USD
+0.13 (0.71%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.54 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
Income Statements
Fiscal Year end for Organon & Co falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6,263 | 6,174 | 6,304 | 8,096 | 9,530 |
Cost Of Goods | 2,515 | 2,294 | 2,382 | 3,347 | 3,621 |
Gross Profit | 3,748 | 3,880 | 3,922 | 4,749 | 5,909 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,506 | 2,325 | 2,393 | 2,069 | 2,354 |
Income After Depreciation & Amortization | 1,242 | 1,555 | 1,529 | 2,680 | 3,555 |
Non-Operating Income | -42 | -11 | 0 | 0 | 0 |
Interest Expense | 527 | 422 | 0 | 0 | 0 |
Pretax Income | 673 | 1,122 | 1,529 | 2,680 | 3,555 |
Income Taxes | -350 | 205 | 178 | 520 | 337 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,023 | 917 | 1,351 | 2,160 | 3,218 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1,023 | 917 | 1,351 | 2,160 | 3,218 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,478 | 1,767 | 1,724 | 2,837 | 3,909 |
Depreciation & Amortization (Cash Flow) | 236 | 212 | 195 | 157 | 354 |
Income After Depreciation & Amortization | 1,242 | 1,555 | 1,529 | 2,680 | 3,555 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 256.27 | 255.17 | 254.19 | NA | NA |
Diluted EPS Before Non-Recurring Items | 4.09 | 5.03 | 6.54 | NA | NA |
Diluted Net EPS (GAAP) | 3.99 | 3.59 | 5.31 | NA | NA |
Fiscal Year end for Organon & Co falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,598.00 | 1,519.00 | 1,608.00 | 1,538.00 |
Cost Of Goods | NA | 683.00 | 612.00 | 640.00 | 580.00 |
Gross Profit | NA | 915.00 | 907.00 | 968.00 | 958.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 665.00 | 679.00 | 580.00 | 582.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 250.00 | 228.00 | 388.00 | 376.00 |
Non-Operating Income | NA | -17.00 | -14.00 | -2.00 | -9.00 |
Interest Expense | NA | 129.00 | 134.00 | 132.00 | 132.00 |
Pretax Income | NA | 104.00 | 80.00 | 254.00 | 235.00 |
Income Taxes | NA | -442.00 | 22.00 | 12.00 | 58.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 546.00 | 58.00 | 242.00 | 177.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 546.00 | 58.00 | 242.00 | 177.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 256.59 | 256.35 | 255.95 | 256.17 |
Diluted EPS Before Non-Recurring Items | NA | 0.87 | 0.78 | 1.31 | 1.08 |
Diluted Net EPS (GAAP) | NA | 2.12 | 0.23 | 0.95 | 0.69 |